Breaking News: Noah Medical's Galaxy System Achieves Perfect Accuracy in Surgical Robot Study

Noah Medical, based in San Carlos, California, has announced groundbreaking results from a recent study evaluating its Galaxy System surgical robot platform. Designed to provide bronchoscopic visualization and access for diagnostic and therapeutic procedures in patient airways, the Galaxy System boasts advanced imaging technologies aimed at improving diagnostic yield and tool-in-lesion accuracy.

The study, known as MATCH, focused on assessing the "tool-in-lesion" accuracy of the Galaxy System, with results published in the Journal of Bronchology & Interventional Pulmonology. According to the findings, the Galaxy's TiLT Technology achieved an impressive 100% successful navigation to lesion, along with a diagnostic yield of 100% and tool-in-lesion accuracy of 95%. The TiLT Technology incorporates integrated tomosynthesis and augmented fluoroscopy, enhancing the precision and effectiveness of surgical interventions.

Noah Medical's CEO and founder, Jian Zhang, emphasized the collaborative effort between physicians and engineers in designing the Galaxy System. Zhang expressed pride in the study results, highlighting the system's advanced design and technology. These findings come shortly after the FDA clearance of the Galaxy System in March and the initiation of the first-in-human trial in Australia, marking significant milestones in the platform's commercialization journey.

The MATCH study, conducted to evaluate tool-in-lesion accuracy in peripheral lung nodules using a porcine model, provides critical insights into addressing challenges associated with CT-to-body divergence in robotic platforms. By confirming a high rate of tool-in-lesion accuracy, the Galaxy System has the potential to increase the rate of definitive diagnosis, ultimately benefiting patients worldwide.

Principal investigator Dr. Krish Bhadra, from CHI Memorial Hospital in Chattanooga, Tennessee, hailed the Galaxy System as a pioneering advancement in image-guided robotics. Bhadra emphasized the importance of the study's findings in overcoming CT-to-body divergence issues in interventional pulmonology, bringing the medical community one step closer to solving longstanding challenges in surgical navigation and precision.

In conclusion, Noah Medical's Galaxy System has demonstrated unparalleled accuracy and efficacy in surgical robot navigation, setting a new standard for image-guided robotics in diagnostic and therapeutic procedures. With continued advancements and clinical validation, the Galaxy System holds promise for transforming patient care and enhancing the quality of life for individuals worldwide.